Category Archives: Research and Development

HIV vaccine development, combination prevention, antiretroviral treatment top agenda as briefing eyes progress against 2.3 million new infections

By on .

With the wait for a vaccine against HIV stretching back to when the virus was first identified 30 years ago, how do you measure progress? You can measure it against the time vaccine development has taken since the field began. Margaret McGlynn, who has been involved in the marketing of more than a dozen vaccines, […]

Fauci: HIV imaging yields “significant advance” in vaccine inquiry

By on .

For 15 years scientists have worked to get a clear enough picture of how the protein surrounding the virus that leads to AIDS interacts with antibodies, to guide the development of a vaccine that would instigate an effective immune response. For years, the delicate and complicated structure of that protein has made that difficult, and […]

A TB vaccine? GHIT Fund eyes that prize, and more as public private partnership takes off

By on .

What does it take to move research from recognition of need to realization? Increasingly, in a funding landscape that has seen an actual decline in dollars to develop new tools for tuberculosis along with other diseases, the answer has been public-private partnerships. The most recent prominent example is the Global Health Innovative Technology — GHIT […]

Can a vaginal ring be part of HIV prevention arsenal by 2016?

By on .

With up to $40 million in two five-year USAID grants, HIV prevention for women gathers speed . . . A little more than 10 years ago, a New York Times reporter interviewing International Partnership for Microbicides chief executive Zeda Rosenberg pointed to estimates putting the earliest possible marketing of topical product women could use and […]